Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond.

Volume: 14, Issue: 1, Pages: 1 - 18
Published: Jul 23, 2021
Abstract
The pace of innovation of multiple myeloma therapy in recent years is remarkable with the advent of monoclonal antibodies and the approval of novel agents with new mechanisms of action. Emerging therapies are on the horizon for clinical approval with significant implications in extending patient survival and advancing closer to the goal of a cure, especially in areas of immunotherapy such as chimeric antigen receptor T cells, bispecific T cell...
Paper Details
Title
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond.
Published Date
Jul 23, 2021
Volume
14
Issue
1
Pages
1 - 18
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.